Targets of c-Jun NH2-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression

Cancer Research

Volumn 62, Issue 11, 2002, Pages 3257-3263

  Potapova, Olga ^a   Gorospe, Myriam ^a   Dougherty, Ryan H ^a   Holbrook, Nikki J ^a   Anisimov, Sergey V ^b   Boheler, Kenneth R ^b   Gaarde, William A ^c  

^a Laboratory of Cellular and Molecular Biology   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL CYCLE; CELL GROWTH; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RNA METABOLISM; SIGNAL TRANSDUCTION; STRESS; TIME SERIES ANALYSIS; TUMOR GROWTH;

APOPTOSIS; BLOTTING, NORTHERN; CELL CYCLE; CELL DIVISION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0036606371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Signal transduction by the JNK group of MAP kinases
2. Signaling by the JNK group of MAP kinases, c-jun N-terminal kinase
3. The c-Jun N-terminal kinase pathway and apoptotic signaling
4. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development
5. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors
6. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases
7. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase
8. Defective T cell differentiation in the absence of Jnkl
9. Differentiation of CD4+ T cells to Thl cells requires MAP kinase JNK2
10. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development
11. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
12. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
13. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes
14. A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules
15. Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family
16. Evaluation of biological role of c-Jun N-terminal kinase using an antisense approach
17. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells
18. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner
19. Serial analysis of gene expression
20. Gene discovery using the serial analysis of gene expression technique: Implications for cancer research
21. Identification and classification of p53-regulated genes
22. SAGE transcript profiles for p53-dependent growth regulation
23. The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells
24. Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters
25. Genomic sequencing
26. Substantially enhanced cloning efficiency of SAGE (Serial Analysis of Gene Expression) by adding a heating step to the original protocol
27. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
28. Functional analysis of the 5' promoter region of the rat lamin A gene
29. Amino acid sequence of a novel integrin β 4 subunit and primary expression of the mRNA in epithelial cells
30. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization
31. HMG-I/Y, a new c-Myc target gene and potential oncogene
32. Functions of Lsm proteins in mRNA degradation and splicing
33. Characterization of the split hand/split foot malformation locus SHFMI at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development
34. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion
35. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement
36. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
37. Pushing the envelope on lipodystrophy
38. The HMG I proteins: Dynamic roles in gene activation, development, and tumorigenesis
39. Cellular and molecular determinants of cisplatin resistance
40. CROP/Luc7A, a novel serine/arginine-rich nuclear protein, isolated from cisplatin-resistant cell line
41. Protective role for c-Jun in the cellular response to DNA damage
42. Expression of a novel immediate early gene during 12-O-tetradecanoylphorbol-13-acetate-induced macrophagic differentiation of HL-60 cells
43. Caveolins in cholesterol trafficking and signal transduction: Implications for human disease
44. A requirement for caveolin-I and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth
45. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences
46. Caveolin-1, a putative tumour suppressor gene
47. AP-1 in cell proliferation and survival
48. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway
49. c-Jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells